NeuroMetrix, a medical device company focused on the treatment and management of the neurological complications of diabetes, has announced a national distribution agreement with DJO Global for the Sensus pain management system.
Sensus is a convenient and wearable non-invasive electrical nerve stimulator that offers patients a fast-acting, non-narcotic option for relief from chronic pain. The device is lightweight and can be worn during the day while remaining active, or at night while sleeping.
It is optimally designed for people with diabetes that suffer from chronic pain. The most common cause of such pain is painful diabetic neuropathy (PDN).
The Recovery Sciences division of DJO is a leading manufacturer and distributor of electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement.
It deploys a direct US sales force. Recovery Sciences will market SENSUS primarily to pain management and podiatry clinics, as well as in endocrinology, internal medicine, primary care and neurology clinics. This agreement follows a SENSUS market pilot conducted in the second half of 2013.
DJO Global Recovery Sciences division business development senior vice president Rick Rioles noted Sensus nicely compliments the Recovery Sciences electrotherapy product offerings for pain management.
"We believe that the diabetic pain market represents a growth opportunity for electrotherapy as it addresses important unmet clinical needs. We are impressed by the SENSUS technology and its status as the only transcutaneous electrical nerve stimulator cleared for use during sleep. We believe it will have strong appeal in our target markets," Rioles added.